Rosalie A Scholtes Selected Research

Biomarkers (Surrogate Marker)

5/2022

The Adaptive Renal Response for Volume Homeostasis During 2 Weeks of Dapagliflozin Treatment in People With Type 2 Diabetes and Preserved Renal Function on a Sodium-Controlled Diet.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rosalie A Scholtes Research Topics

Disease

9	Type 2 Diabetes Mellitus (MODY) 04/2023 - 01/2019
2	Body Weight (Weight, Body) 04/2023 - 01/2020
2	Heart Failure 01/2021 - 01/2019
2	Albuminuria 01/2020 - 01/2019
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 01/2019
2	Diabetic Nephropathies (Diabetic Nephropathy) 01/2019 - 01/2019
1	Stroke (Strokes) 01/2019
1	Acute Kidney Injury (Acute Renal Failure) 01/2019
1	Hyperkalemia 01/2019
1	Hyperglycemia 01/2019

Drug/Important Bio-Agent (IBA)

5	SodiumIBA 04/2023 - 01/2020
5	Sodium-Glucose Transporter 2 InhibitorsIBA 04/2023 - 01/2019
5	Glucose (Dextrose)FDA LinkGeneric 04/2023 - 01/2019
4	dapagliflozinIBA 04/2023 - 01/2020
4	Sodium-Glucose Transport ProteinsIBA 05/2021 - 01/2019
3	empagliflozinIBA 04/2023 - 01/2019
2	Angiotensin Receptors (Angiotensin II Receptor)IBA 12/2022 - 01/2019
2	Natriuretic AgentsIBA 01/2021 - 01/2019
1	Losartan (Cozaar)FDA LinkGeneric 01/2023
1	CreatinineIBA 05/2022
1	Hormones (Hormone)IBA 05/2022
1	AlbuminsIBA 05/2022
1	Biomarkers (Surrogate Marker)IBA 05/2022
1	Complement System Proteins (Complement)IBA 01/2020
1	Uric Acid (Urate)IBA 01/2020
1	MineralocorticoidsIBA 01/2019
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2019
1	ReninIBA 01/2019
1	finerenoneIBA 01/2019
1	DiureticsIBA 01/2019
1	Mineralocorticoid Receptor AntagonistsIBA 01/2019
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2019

Therapy/Procedure

1	Therapeutics 01/2019